Marcella Ducca is Co-Chair of the Atlanta Products Liability Litigation Group and a shareholder at the firm. Marcella focuses her practice on the representation and defense of manufacturers in products liability litigation, with an emphasis on pharmaceutical, medical device, and health care litigation. She litigates a variety of complex matters in both state and federal courts, including multidistrict litigations ("MDLs") and mass torts. In addition, Marcella regularly defends major hospitals, physicians, and other healthcare providers in alleged medical malpractice cases.
Marcella is a senior leader on GT’s mass tort litigation teams, managing largescale national litigation as well as individual catastrophic injury and wrongful death cases. Marcella’s practice has been focused on medical devices, particularly women’s health devices and women’s health consumer products. In what has been called by some the most complicated mass tort in history, Marcella selected, retained, and managed dozens of trial experts and also helped build strategy for depositions of thousands of plaintiffs and physicians across the country, deposing many of them. She has also been a key member of several trial teams, including taking on responsibility for day-to-day case management, development of case strategy, and all aspects of fact and expert discovery. In one successful trial—a complete defense verdict when the plaintiff was seeking $28 million in damages—Marcella was instrumental in steering the causation defense and handling the parties’ medical expert witnesses.
Marcella currently oversees all aspects of a nationwide litigation involving inferior vena cava (IVC) filters, including strategy, motion practice, fact discovery, expert discovery, and trial workup. She has defended other mass torts, including transvaginal mesh, talcum powder, hernia mesh, and testosterone replacement therapy. Beyond her mass tort work, Marcella is involved in the defense of claims against one of the nation's largest medical device sterilization providers. Marcella recently secured the first dismissal of a medical device manufacturer on preemption grounds in the State of Alabama.
Marcella is listed in The Legal 500 United States, “Dispute Resolution – Product Liability, Mass Tort and Class Action – Defense: Pharmaceuticals and Medical Devices” (2020). She has been selected by Super Lawyers magazine as a Georgia Super Lawyers “Rising Star” from 2013 to the present, was selected as a “Rising Star” by Law360 in 2018, was featured in American Lawyer Media’s Daily Report “On the Rise” section in 2015, and was selected by the American Bar Association (ABA) as one of its “On the Rise: Top 40 Young Lawyers” in the country for 2017. Marcella is a leader on the team that was named The American Lawyer’s “Product Liability Litigation Department of the Year” and “Georgia Regional Litigation Department of the Year” for 2018.
Marcella is a frequent speaker on emerging issues in complex litigation and product liability law. She recently presented at the International Society for Pharmacoeconomics and Outcomes Research on “Proactive Post-Market Surveillance, 510(k) Update, and Real-World Evidence;” DeviceTalks Minnesota, “M&A, IP, and Product Liability Trends Impacting MedTech;” the Defense Research Institute’s Asbestos Medicine Seminar; ACI’s Drug & Medical Device Litigation Conference; and the Minnesota Women Lawyers’ Annual Conference.
Marcella is a member of the Emerging Leaders Board of Advisors at The Institute for Complex Litigation and Mass Claims at Emory University School of Law. She has also held multiple roles in the Young Lawyers Division (YLD) of the ABA.
- Products liability
- Pharmaceutical, medical device and health care litigation
- Multidistrict litigation
- Medical malpractice
- Commercial litigation